Dracunculifoside I



Compound IDCDAMM02828
Common nameDracunculifoside I
IUPAC name[3,4-dihydroxy-5-[[3,4,5-trihydroxy-6-[2-hydroxy-5-(3-oxobutyl)phenoxy]oxan-2-yl]methoxy]oxolan-3-yl]methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
Molecular formulaC30H36O15

Experimental data

Retention time18.11
Adduct[M+H]+
Actual mz637.208
Theoretical mz637.212
Error7.02
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.5385

Identifiers and class information

Inchi keyDNTOGGCBATUQGV-YGJDHEKMNA-N
SmilesO=C(OCC1(O)COC(OCC2OC(OC3=CC(=CC=C3O)CCC(=O)C)C(O)C(O)C2O)C1O)C=CC4=CC=C(O)C(O)=C4
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)8
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)21
Number of reactive functional groups (#rtvFG)4
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)636.605
Computed dipole moment(dipole)6.966
Total solvent accessible surface area (SASA)925.113
Hydrophobic component of SASA (FOSA)290.901
Hydrophilic component of SASA (FISA)401.234
Pie component of the SASA (PISA)232.979
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1776.2
Number of hydrogen bond donors (donorHB)8
Number of hydrogen bond acceptors (accptHB)19.65
Free energy of solvation of dipole (dip^2/V)0.0273173
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0600776
Globularity descriptor (glob)0.76671
Predicted polarizability in cubic angstroms (QPpolrz)53.67
Predicted hexadecane/gas partition coefficient (QPlogPC16)21.168
Predicted octanol/gas partition coefficient (QPlogPoct)41.299
Predicted water/gas partition coefficient (QPlogPw)32.699
Predicted octanol/water partition coefficient (QPlogPo/w)-0.925
Predicted aqueous solubility (QPlogS)-2.833
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.767
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.418
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1.552
Predicted brain/blood partition coefficient (QPlogBB)-5.253
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.455
Predicted skin permeability, log Kp (QPlogKp)-6.077
PM3 calculated ionization potential (IP(ev))8.793
PM3 calculated electron affinity (EA(eV))0.906
Number of likely metabolic reactions (#metab)10
Prediction of binding to human serum albumin (QPlogKhsa)-1.246
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)258.626
Number of nitrogen and oxygen atoms (#NandO)15
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SEA
P02766TTRTransthyretinT86462SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P23280CA6Carbonic anhydrase VIT06569SEA
P22748CA4Carbonic anhydrase IVT53378SEA
P15121AKR1B1Aldose reductaseT26623SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P60568IL2Interleukin-2T61698SEA
Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
P10636MAPTMicrotubule-associated protein tauT45593SEA
Q16236NFE2L2Nuclear factor erythroid 2-related factor 2T88505SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
Q8N183NDUFAF2HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2T01453SEA
Q9P0J0NDUFA13Mitochondrial complex IT82391SEA
Q9Y6M9NDUFB9HUMAN NADH:ubiquinone oxidoreductase subunit B9T01465SEA
Q8N183NDUFAF2HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2T01453SEA
P03897MT-ND3NADH dehydrogenaseT77195SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T86462DI0026Amyloidosis[ICD-11: 5D00]P02766TTR
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T26623DI0298Neuropathy[ICD-11: 8C0Z]P15121AKR1B1
T26623DI0366Rheumatoid arthritis[ICD-11: FA20]P15121AKR1B1
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T45593DI0012Acute myeloid leukaemia[ICD-11: 2A60]P10636MAPT
T45593DI0025Alzheimer disease[ICD-11: 8A20]P10636MAPT
T45593DI0265Mild neurocognitive disorder[ICD-11: 6D71]P10636MAPT
T88505DI0038Ataxic disorder[ICD-11: 8A03]Q16236NFE2L2
T82391DI0069Cardiomyopathy[ICD-11: BC43]Q9P0J0NDUFA13
T77195DI0331Parkinsonism[ICD-11: 8A00]P03897MT-ND3

Copyright © 2025